Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited Free Cash Flow for the year ending March 31, 2024: USD 32.50 K

Vaishali Pharma Limited Free Cash Flow is USD 32.50 K for the year ending March 31, 2024, a -65.86% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Vaishali Pharma Limited Free Cash Flow for the year ending March 31, 2023 was USD 95.21 K, a 59.31% change year over year.
Vaishali Pharma Limited Free Cash Flow for the year ending March 31, 2022 was USD 59.76 K, a -76.79% change year over year.
Vaishali Pharma Limited Free Cash Flow for the year ending March 31, 2021 was USD 257.45 K, a -38.73% change year over year.
Vaishali Pharma Limited Free Cash Flow for the year ending March 31, 2020 was USD 420.16 K, a 14.42% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO	Mr. Hemanth Damodar Pathak
IPO Date	Aug. 22, 2017
Location	India
Headquarters	706 to 709, Aravalli Business Center
Employees	27
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Key trends

Past 5 years